Advert: GoIndustry032010Leader
line
Menu top
Menu bottom
Website and Archive search
  Go
JobSearch
  Go
  Advert: Europharm100312
MAGAZINE AUDIT BY
ABC Logo
Where am I? > Home > Industry News > UK News
Hline
Advert: SAS_sky_FEB10
LATEST UK NEWS Rss Feed
Prostrakan, Axis-Shield post double-digit sales growth for 2009
UK-based drugmaker Prostrakan has posted a 41% jump in revenues to £79 million for the year ended December 31, 2009, while Axis-Shield saw its sales climb 13.4% to £96.7 million.

AstraZeneca takes selective approach for emerging markets
AstraZeneca has laid out its plans for growth in the emerging markets which the company notes is not limited to the BRIC (Brazil, Russia, India and China) countries

Vernalis gets $3 million milestone from Novartis
Vernalis has received a cash boost from partner Novartis which is progressing one of the UK’s oncology treatments into mid-stage trials

NICE updates psoriatic arthritis guidance, adding Humira
NICE has this week published draft guidance recommending Wyeth’s Enbrel, Abbott’s Humira and Schering-Plough’s Remicade as treatments for psoriatic arthritis, under certain conditions.

Failures over dementia cannot continue, say MPs
Despite Department of Health assurances that dementia would be a national health priority, it has not been given the same status as cancer and stroke, and the Department does not know how the first £60 million of dementia funding has been spent, say MPs, in a damning new report published today.

GSK's Revolade approved in EU, will take on Amgen's Nplate
GlaxoSmithKline and partner Ligand Pharmaceuticals are celebrating the news that their blood disorder drug Revolade has gained marketing approval in the European Union

More Headlines
Arrow BMA calls for suspension of Summary Care Records launch
Arrow New legal rights for patients added to NHS Constitution
Arrow Bayer Schering Pharma’s antibacterial Avelox IV granted UK licence
Arrow GSK forms second inflammatory pact with Cellzome
Arrow AZ falls foul of ABPI Code of Practice with Seroquel ad
Arrow Ark/Oxford BioMedica merger touted as Cerepro file is pulled
Arrow Government gets tough on parallel exports
Arrow Remicade and Humira clear another hurdle to NHS use
Arrow Roche’s MabThera on the brink of NICE green light for leukaemia
Arrow Medco Health bursts onto UK pharmacy homecare market
Arrow Vernalis to clear debt with Frova royalties buy-back
Arrow Court backs five-year exclusivity for Shire's ADHD drug Vyvanse

Older >
 
Join PharmaTimes Directors Club
Arrow Find out more
PharmaTimes Club for Directors Secretaries
Arrow Learn more
LATEST JOBS
Arrow   Project Director Pharmaceutical Market Research
Arrow   Territory Manger- North-West
Arrow   Account Manager/Senior Account Manager Flexible Remote Home Working
Arrow   Looking to make a move into Market Access consultancy?
Arrow   Healthcare Strategy Manager
Arrow   Pain Sales Specialist
Arrow   UK Partnership Development Manager
Arrow   ASSOCIATE CREATIVE COPY DIRECTOR
Arrow   Junior Editor, Healthcare Communications
Arrow   Medical writer/Senior & Principal writer opportunities – All UK Location
 
line
flickrtwitteryoutube